Published in

American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(36), p. TPS3135-TPS3135

DOI: 10.1200/jco.2018.36.15_suppl.tps3135

Links

Tools

Export citation

Search in Google Scholar

HepaVac-101 first-in-man therapeutic cancer vaccine phase I/II clinical trial for hepatocellular carcinoma patients.

Journal article published in 2018 by Luigi Buonaguro, Andrea Mayer-Mokler, Roberto Accolla, Yuk Ting Ma, Regina Heidenreich, Antonio Avallone, Ester Simeone, Alfred Koenigsrainer, Markus Loeffler, Cecile Gouttefangeas, Christian Flohr, Joerg Ludwig, Hans-Georg Rammensee, Mercedes Iñarrairaegui, Sven Francque and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO